http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CO-5660262-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_132aa5ddba376cda52c2bedb26765245 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4406 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-166 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-475 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4406 |
| filingDate | 2005-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_98bb500ba461f4cd23b8a6ac8a029e7e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_850fb7d440c7ece0102bf3b81512fb0c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8852f8340d1e5695e35fa6d04745ffff http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f84496663b599f02fb6aabf5994e7500 |
| publicationDate | 2006-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CO-5660262-A2 |
| titleOfInvention | PHARMACEUTICAL COMPOSITION CONTAINING A HISTONE DEACETILASE INHIBITOR |
| abstract | 1. A pharmaceutical composition or combination comprising as active ingredients: a) .- at least one of the benzamide derivatives which is a histone deacetylase inhibitor substance, or a pharmaceutically acceptable salt thereof, represented by the following formula (I): in which A is an optionally substituted phenyl group or an optionally substituted heterocyclic group in which the substituent (s) for the phenyl group or for the heterocyclic group is (are): 1 to 4 substituents selected from the group consisting of a halogen atom, a hydroxyl group, an amino group, a nitro group, a cyano group, an alkyl group having 1 to 4 carbons, an alkoxy group having 1 to 4 carbons, an aminoalkyl group having 1 to 4 carbons, an alkylamino group having 1 to 4 carbons, an acyl group having 1 to 4 carbons, an acylamino group having 1 to 4 carbons, an alkylthio group having 1 to 4 carbons, a perfluoralkyl group that it has 1 to 4 carbons, a perfluoralkyloxy group having 1 to 4 carbons, a carboxyl group, an alkoxycarbonyl group having 1 to 4 carbons, a phenyl group and a heterocyclic group; X is a bond or a part having a selected structure among those illustrated in formula (2): in which e is an integer from 1 to 4; g and m are independently an integer from 0 to 4; R4 is a hydrogen atom or an optionally substituted alkyl group having 1 to 4 carbons, or the acyl group represented by the formula (3): in which R6 is an optionally substituted alkyl group having 1 to 4 carbons, .. . |
| priorityDate | 2003-05-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 26.